29399598|t|Long-Acting Lipoglycopeptides for Gram-Positive Bacteremia at the End of Life to Facilitate Hospice Care: A Report of 3 Cases.
29399598|a|Administering and monitoring intravenous antimicrobials may cause discomfort in patients at the end of life and delay transition to hospice. We describe 3 patients with terminal cancer with methicillin-resistant Staphylococcus aureus, Streptococcus gallolyticus, and Granulicatella adiacens bacteremia who were managed with the long-acting lipoglycopeptide oritavancin to facilitate discharge to hospice.
29399598	12	29	Lipoglycopeptides	Chemical	MESH:D000077427
29399598	48	58	Bacteremia	Disease	MESH:D016470
29399598	207	215	patients	Species	9606
29399598	282	290	patients	Species	9606
29399598	296	311	terminal cancer	Disease	MESH:D009369
29399598	317	328	methicillin	Chemical	MESH:D008712
29399598	339	360	Staphylococcus aureus	Species	1280
29399598	362	388	Streptococcus gallolyticus	Species	315405
29399598	394	417	Granulicatella adiacens	Species	46124
29399598	418	428	bacteremia	Disease	MESH:D016470
29399598	467	483	lipoglycopeptide	Chemical	MESH:D000077427
29399598	484	495	oritavancin	Chemical	MESH:C100708
29399598	Positive_Correlation	MESH:D008712	MESH:D016470
29399598	Association	MESH:D008712	MESH:D009369
29399598	Negative_Correlation	MESH:C100708	MESH:D016470
29399598	Negative_Correlation	MESH:D000077427	MESH:D009369
29399598	Negative_Correlation	MESH:C100708	MESH:D008712
29399598	Negative_Correlation	MESH:D000077427	MESH:D016470
29399598	Negative_Correlation	MESH:C100708	MESH:D009369

